Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2025 Earnings Call Transcript February 19, 2026
Travere Therapeutics, Inc. reports earnings inline with expectations. Reported EPS is $0.03 EPS, expectations were $0.03.
Operator: Good afternoon, and welcome to the Travere Therapeutics Fourth Quarter and Full Year 2025 Financial Results Conference Call. Today’s call is being recorded. At this time, I would like to turn the conference call over to Nivi Nehra, Vice President, Corporate Communications...
